KCAS Bio

We met with key industry leaders at our home office in Union Station to highlight industry commitment to the KC Bio Tech Hub and explain industry opportunities specific to this region. Key focus areas included: 🔬 Strengthening our regional supply chain 👥 Expanding our skilled workforce pipeline 💡 Optimizing capital investment opportunities We were also able to tour the Missouri Biotechnology Association (MOBIO) mobile training lab - a regional asset that brings workforce training to the students throughout Missouri. Thank you: Spencer Chestnut, Catalent Pharma Solutions  John Bucksath, KCAS Bio Joe Payne, Scorpius BioManufacturing, Inc. Kelly Gillespie, Missouri Biotechnology Association (MOBIO)

Oligonucleotide therapeutics have recently seen significant developments in drug development, yet bioanalytical challenges—like chromatographic retention, stability, and complex extractions—persist. At KCAS Bio, we’ve built robust strategies to overcome these obstacles: 🔹 Chromatographic Precision: Our optimized IP-RP chromatography ensures high resolution and response, fine-tuned with select ion-pair reagents. 🔹 Optimized Extraction Techniques: Tailored approaches, including mixed-mode SPE, provide precise quantitation in challenging matrices. Read our blog to discover more about how KCAS Bio is leading oligonucleotide quantitation and bringing new possibilities to life. https://lnkd.in/gCydCxaw #Biotech #Oligonucleotides #DrugDevelopment #KCASBio

Unlock Insights on Biomarkers in Bioanalytical Testing! Biomarkers are a critical aspect of bioanalytical testing, as they provide a vast amount of information, from the effects of a drug on the subject to determining the drug’s mechanism of action and the correct dose for a patient. If you currently outsource bioanalytical studies, develop and validate biomarker assays or just want to learn more about biomarkers, you'll want to watch our webinar: "Biomarker Assay Development: Qualification Vs Validation Debate." During the webinar, KCAS Bio's Lindsay Rutherford, Ph.D. discusses: - Determining the right level of biomarker development - Selecting the appropriate platforms and assays - Understanding how to tailor biomarker development to meet specific study needs Click the link to gain access to this exclusive content from KCAS Bio and Bioanalysis Zone. https://lnkd.in/gGcmc6HC #BioanalyticalTesting #Biomarkers #CRO #Biopharma #ClinicalResearch

We’re honored to be included among the incredible companies on the Kansas City Business Journal's “Fastest-Growing Area Businesses” list and thrilled to be ranked #71! Thank you to everyone who has contributed to our growth and success. Congratulations to all the companies featured, and a big thank you to our dedicated team as we continue to accelerate science. #KCBJ #BusinessGrowth #KansasCity

Thank you SCIEX for bringing together industry leaders, including KCAS Bio's John Perkins, Ph.D, to discuss the latest insights and innovations in #Pharma.

Our team, CHRISTINE FRANKOVIC, Dawn Dufield Ph.D, Derek McCartney, Alexander Popov, MBA, Jason Hannah and Heather Sharbaugh had a fantastic time hosting the KCAS Bio exclusive happy hour during #PharmSci360 in Salt Lake City. The event was a huge success. Thank you to everyone who attended and thank you to our co-hosts Olon USA and Ascendia for a great event. We look forward to continuing these conversations and creating partnerships that move the industry forward. #BioanalyticalResearch #CRO #Collaboration #Innovation #PharmaBiotech

It's a full house for KCAS Bio's presentation on Stage 2 at #PharmSci360 for Dawn Dufield, Ph.D. She's discussing PK methods, platforms, and Immunogenicity approaches specifically for ADCs and conjugated therapies, with real-world case studies to deepen the insights. Didn't have a chance to attend the talk? Contact us at www.kcasbio.com and we will get you the details. If you're at #PharmSci360, stop by booth #2511 to meet the entire team and learn how KCAS Bio’s innovative bioanalytical services can support your drug development needs. We are Science Accelerated.

Join us in welcoming our newest team members to KCAS Bio! We’re excited to have you on board as we continue advancing science together. #OneKCAS #Welcome

#PharmSci360 is here! Visit KCAS Bio at Booth #2511 to meet our team including John Bucksath (CEO), CHRISTINE FRANKOVIC, Derek McCartney and Dawn Dufield, Ph.D. to learn how our innovative bioanalytical services can support your drug development needs. At KCAS Bio, we are Science Accelerated.

See you soon at #AAPSPharmSci360 Welcome Reception on Sunday, October 20th.